We strive to provide patient-focused, personalized, multi-disciplinary care for gastrointestinal (GI) cancers. Our specialized providers in Medical Oncology (chemotherapy and targeted therapies), Surgical Oncology, Radiation Oncology, Pathology, Molecular Pathology, Radiology, Interventional Radiology, Nuclear Medicine, Gastroenterology (both Hepatology and Interventional Endoscopy), Nutrition, and Integrative Medicine work together to achieve the best outcomes for our patients. We have weekly GI cancer tumor boards, where our specialists come together to discuss patients and patient care.
In July 2011, I joined the University of Colorado School of Medicine faculty. I trained in internal medicine at the University of Colorado, where I also served as a Chief Medical Resident. I completed his fellowship training in medical oncology at the University of Texas MD Anderson Cancer Center and served as the Chief Medical Oncology Fellow in 2010. Currently, I serve as the Director of GI Medical Oncology at the University of Colorado Cancer Center, the Vice-Chair of the National Cancer Institute Colon Cancer Task Force, and on the National Comprehensive Cancer Network (NCCN) Panel for Neuroendocrine Cancers.
Qualifications and experience
- Medical Oncology, Internal Medicine, Digestive System, Cancers - Pancreatic Cancer, Cancers - Cancer Prevention, Cancers - Cancer Medicine, Cancers - Biliary Cancer, Digestive System - Gastroenterology (Stomach, Bowel, General GI Problems), Cancers - Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver), Cancers - Colorectal Cancer, Cancers
- Languages spoken
University of Texas M D Anderson Cancer Center Program (2011)
University of Colorado (University Hospital) Program (2005)
Wake Forest University School of Medicine (2004)
University of Colorado (University Hospital) Program (2008)
University of North Carolina–Chapel Hill (NC) (2000)
- Clinical interest for patients
I am interested in Gastrointestinal Cancers (Colorectal, Pancreatic, Gastric, Esophageal, Hepatocellular, Gallbladder, Bile Duct, Anal, Carcinoma of Unknown (Primary), Drug Development (Experimental Therapeutics) and Translational Research.
- Research interest for patients
I am a member of the Developmental Therapeutics (phase I clinical trials) and Gastrointestinal (GI) Medical Oncology Program. These comprehensive programs include multidisciplinary cancer clinics, tumor boards, and research endeavors. I am interested in resistance mechanisms to targeted therapy in GI cancers, and I was awarded the Conquer Cancer Foundation Career Development Award, NIH K23 grant, and a NIH R01 grant to study targeted therapies in colorectal cancer. I am also investigating novel therapeutic strategies to more effectively treat and prevent colorectal cancer in young adults.